Table 1.
Ref. | No. screened | Anti-HCV+ | HCV RNA+ |
Hillemanns et al[3] | 3712 | 0.94% | 57% |
Conte et al[4] | 15250 | 2.40% | 72% |
Ward et al[5] | 4729 | 0.80% | 72% |
Baldo et al[6] | 4008 | 1.70% | 42.50% |
Goldberg et al[7] | 3548 | 0.60% | NA |
Kumar et al[8] | 8130 | 1.03% | NA |
Sami et al[9] | 5902 | 1.80% | NA |
Ohto et al[10] | 22664 | 0.50% | 54% |
Seisdedos et al[11] | 474539 | 0.15% | NA |
Ugbebor et al[12] | 5760 | 3.60% | NA |
Pinto et al[13] | 115386 | 0.10% | NA |
Urbanus et al[14] | 4563 | 0.30% | NA |
Mean | 1.16% | 59.75% |
HCV: Hepatitis C virus; NA: Not available.